Journal of Clinical Endocrinology & Metabolism, Vol 78, 1510-1514, Copyright © 1994 by Endocrine Society

ARTICLES

Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin- dependent (type II) diabetic patients

G Paolisso, A Scheen, D Cozzolino, G Di Maro, M Varricchio, F D'Onofrio and PJ Lefebvre
Department of Geriatric Medicine and Metabolic Diseases, First Medical School, University of Naples, Italy.

The aim of the present study was to investigate the effects of magnesium supplementation on glucose uptake and substrate oxidation in noninsulin-dependent (type II) diabetic patients. Nine elderly non- obese noninsulin-dependent (type II) diabetic patients, treated by diet only, participated in the study, which was designed as randomized, double blind, and cross-over. Each patient was followed up for a prestudy period of 3 weeks before inviting him/her to receive placebo or magnesium supplementation (15.8 mmol/day) for 4 weeks. At the end of each treatment period, a euglycemic hyperinsulinemic glucose clamp with simultaneous D-[3-3H]glucose infusion and indirect calorimetry was performed. Magnesium supplementation resulted in significantly increased plasma and erythrocyte magnesium levels, whereas body weight and fasting plasma glucose did not change. In the last 60 min of the glucose clamp, insulin-mediated glucose disappearance, total body glucose disposal (24.5 +/- 0.4 vs. 28.2 +/- 0.7 mumol/kg.min; P < 0.005), and glucose oxidation (13.0 +/- 0.4 vs. 16.3 +/- 0.8 mumol/kg.min; P < 0.01) were increased after chronic magnesium supplementation. Endogenous glucose production, nonoxidative glucose disposal, lipid and protein oxidation, and insulin MCR were not affected. In conclusion, a 4-week magnesium supplementation improves insulin sensitivity and glucose oxidation in the course of a euglycemic- hyperinsulinemic glucose clamp in noninsulin-dependent diabetic patients. Long term studies are needed to determine whether magnesium supplementation is useful in the management of type II diabetes.

This article has been cited by other articles:

				H. I Katcher, R. S Legro, A. R Kunselman, P. J Gillies, L. M Demers, D. M Bagshaw, and P. M Kris-Etherton The effects of a whole grain enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome Am. J. Clinical Nutrition, January 1, 2008; 87(1): 79 - 90. [Abstract] [Full Text] [PDF]

				F. H. Nielsen, D. B. Milne, L. M. Klevay, S. Gallagher, and L. Johnson Dietary Magnesium Deficiency Induces Heart Rhythm Changes, Impairs Glucose Tolerance, and Decreases Serum Cholesterol in Post Menopausal Women J. Am. Coll. Nutr., April 1, 2007; 26(2): 121 - 132. [Abstract] [Full Text] [PDF]

				S. Bo, M. Durazzo, S. Guidi, M. Carello, C. Sacerdote, B. Silli, R. Rosato, M. Cassader, L. Gentile, and G. Pagano Dietary magnesium and fiber intakes and inflammatory and metabolic indicators in middle-aged subjects from a population-based cohort. Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1062 - 1069. [Abstract] [Full Text] [PDF]

				R. Lopez-Ridaura, W. C. Willett, E. B. Rimm, S. Liu, M. J. Stampfer, J. E. Manson, and F. B. Hu Magnesium Intake and Risk of Type 2 Diabetes in Men and Women Diabetes Care, January 1, 2004; 27(1): 134 - 140. [Abstract] [Full Text] [PDF]

				J. L. Nadler A New Dietary Approach to Reduce the Risk of Type 2 Diabetes? Diabetes Care, January 1, 2004; 27(1): 270 - 271. [Full Text] [PDF]

				M. Rodriguez-Moran and F. Guerrero-Romero Oral Magnesium Supplementation Improves Insulin Sensitivity and Metabolic Control in Type 2 Diabetic Subjects: A randomized double-blind controlled trial Diabetes Care, April 1, 2003; 26(4): 1147 - 1152. [Abstract] [Full Text] [PDF]

				B. S. O'Connell Select Vitamins and Minerals in the Management of Diabetes Diabetes Spectr, August 1, 2001; 14(3): 133 - 148. [Abstract] [Full Text] [PDF]

				W. H. L. Kao, A. R. Folsom, F. J. Nieto, J.-P. Mo, R. L. Watson, and F. L. Brancati Serum and Dietary Magnesium and the Risk for Type 2 Diabetes Mellitus: The Atherosclerosis Risk in Communities Study Arch Intern Med, October 11, 1999; 159(18): 2151 - 2159. [Abstract] [Full Text] [PDF]

				M. Barbagallo, L. J. Dominguez, M. R. Tagliamonte, L. M. Resnick, and G. Paolisso Effects of Vitamin E and Glutathione on Glucose Metabolism : Role of Magnesium Hypertension, October 1, 1999; 34(4): 1002 - 1006. [Abstract] [Full Text] [PDF]

				M. Barbagallo, L. J. Dominguez, M. R. Tagliamonte, L. M. Resnick, and G. Paolisso Effects of Glutathione on Red Blood Cell Intracellular Magnesium : Relation to Glucose Metabolism Hypertension, July 1, 1999; 34(1): 76 - 82. [Abstract] [Full Text] [PDF]

				L. De Franceschi, C. Brugnara, and Y. Beuzard Dietary Magnesium Supplementation Ameliorates Anemia in a Mouse Model of beta -Thalassemia Blood, August 1, 1997; 90(3): 1283 - 1290. [Abstract] [Full Text] [PDF]

				P. T. Delva, C. Pastori, M. Degan, G. D. Montesi, and A. Lechi Intralymphocyte Free Magnesium in a Group of Subjects With Essential Hypertension Hypertension, September 1, 1996; 28(3): 433 - 439. [Abstract] [Full Text]